Please see below information about transactions made under the share buy-back programme for SmartCraft ASA (“SmartCraft”) (Ticker: SMCRT NO). Date on which the share buy-back programme was announced: 5 November 2024. The duration of the buy-back programme: 5 November 2024 until no later than the day before the Issuer's Annual …
India bounced back from their defeat in Gqeberha with a significantly improved batting display, driven by Tilak Varma's maiden T20I century in the third T20I of the four-match series in Centurion on Wednesday, 13 November. India set a record total of 219 at SuperSport Park, becoming the first team in five years to defend a …
92 wickets in 59 matches. Arshdeep Singh, on Wednesday, November 13, broke the record for the most wickets by an Indian fast bowler in T20 internationals after a match-winning spell in the third match of a four-game series against South Africa in Centurion. With figures of 3 for 37 in India's successful defence of 219 …
FIDELITY JAPAN TRUST PLC (the 'Company') TRANSACTION IN OWN SHARES The Board of the Company announces that it has bought into Treasury Number of shares repurchased: 15,000 Date of transaction: 13 November 2024 Average share price paid per share (GBp): 157.330 Lowest share price paid per share (GBp): 156.500 …
FIDELITY CHINA SPECIAL SITUATIONS PLC (the 'Company') TRANSACTION IN OWN SHARES The Board of the Company announces that it has repurchased for cancellation. Number of shares repurchased: 250,000 Date of transaction: 13 November 2024 Average share price paid per share (GBp): 214.690 Lowest share price paid per share (GBp): …
Following his stupendous knock against South Africa in the third T20I match, India batter Tilak Varma said that it was an "incredible feeling" to smash a century after coming back from injury. Tilak Varma played an unbeaten 107-run knock from 56 balls at a strike rate of 191.07. He slammed eight fours and …
Stayble Therapeutics AB ("Stayble" or the "Company") announces positive results from the Company's clinical phase 1b study in lumbar disc herniation (LDH). The study met its primary safety and tolerability endpoint. Additionally, STA363-treated patients showed a statistically significant reduction in disc volume compared to placebo-treated patients. The study met its …
Beijing, China: Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, has announced a long-term strategic partnership with Beijing Biostar Pharmaceuticals Co., Ltd. (2563.HK) (“Biostar”). This collaboration strengthens the commitment of both companies to …
FIDELITY EMERGING MARKETS LIMITED (the 'Company') Legal Entity Identifier: 213800HWWQPUJ4K1GS84 TRANSACTION IN OWN SHARES The Board of the Company announces that it has bought into Treasury. Number of shares repurchased: 11,408 Date of transaction: 13 November 2024 Average share price paid per share (GBp): 688.520 Lowest share …
Abu Dhabi, United Arab Emirates: New venture unveils an advanced suite of data security products to protect data assets against increasing cyber threats Its proprietary technology was developed by experts at Abu Dhabi’s Technology Innovation Institute The Advanced Technology Research Council’s commercialization arm, VentureOne, has launched QuantumGate, …
